Title:
A method for checking activation of the cell by insulin-like growth factor 1
Document Type and Number:
Japanese Patent JP6277127
Kind Code:
B2
Abstract:
Provided herein is technology relating to antagonists that inhibit, reduce, or minimize the interaction of integrin associated protein (IAP) with Src homology 2 (SH2) domain-containing protein tyrosine phosphatase substrate 1 (SHPS1) and particularly, but not exclusively, to compositions comprising such antagonists and methods of treatment comprising administering such antagonists.
Inventors:
Clemmons, David Earl
Mail, Laura A
Mail, Laura A
Application Number:
JP2014527342A
Publication Date:
February 07, 2018
Filing Date:
August 24, 2012
Export Citation:
Assignee:
The University of North Carolina at Chapel Hill
International Classes:
C07K16/18; A61K39/395; A61K49/16; A61P9/00; A61P9/10; A61P13/12; A61P27/02; A61P35/00; A61P43/00; C12N15/02
Foreign References:
| US20100215640 |
Other References:
Immunology, 2002, vol.106, p.564-576
Attorney, Agent or Firm:
Shoichi Okuyama
Arihara Koichi
Matsushima Tetsuo
Hidefumi Kawamura
Ayako Nakamura
Satoshi Morimoto
Kyoko Tsunoda
Yu Tanaka
Tokumoto Koichi
Atsushi Watanabe
Mai Kodama
Akiko Mizushima
Toru Masuya
Arihara Koichi
Matsushima Tetsuo
Hidefumi Kawamura
Ayako Nakamura
Satoshi Morimoto
Kyoko Tsunoda
Yu Tanaka
Tokumoto Koichi
Atsushi Watanabe
Mai Kodama
Akiko Mizushima
Toru Masuya
Previous Patent: The antibody combined with phosphorylcholine (PC) and/or PC conjugate
Next Patent: RECLINING DEVICE
Next Patent: RECLINING DEVICE